Cargando…

Prospective Assessment of the Association Between Circulating Tumor Cells and Control of Brain Disease After Focal Radiation Therapy of Breast Cancer Brain Metastases

PURPOSE: Predicting the risk of early distant brain failure (DBF) is in demand for management decisions in patients who are candidates for local treatment of brain metastases. This study aimed to analyze the association between circulating tumor cells (CTCs) and brain disease control after stereotac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guedes de Castro, Douglas, Braun, Alexcia Camila, Calsavara, Vinicius Fernando, Melo Gondim, Guilherme Rocha, Gobo Silva, Maria Letícia, Chen, Michael Jenwei, Fogaroli, Ricardo Cesar, Ramos, Henderson, Coelho, Tharcisio Machado, Scintini Herbst, Ana Carolina, Abdallah, Emne Ali, Yu, Liao Shin, Fidarova, Elena, Zubizarreta, Eduardo, Assis Pellizzon, Antônio Cássio, Domingos Chinen, Ludmilla Thomé
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071730/ https://www.ncbi.nlm.nih.gov/pubmed/33912738 http://dx.doi.org/10.1016/j.adro.2021.100673

Ejemplares similares

Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control
por: de Castro, Douglas Guedes, et al.
Publicado: (2022)

Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis
por: Coelho, Tharcisio Machado, et al.
Publicado: (2018)

Comparison of hormonal receptor expression and HER2 status between circulating tumor cells and breast cancer metastases
por: Sanches, Solange Moraes, et al.
Publicado: (2021)

Molecular and Kinetic Analyses of Circulating Tumor Cells as Predictive Markers of Treatment Response in Locally Advanced Rectal Cancer Patients
por: Troncarelli Flores, Bianca C., et al.
Publicado: (2019)

Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

High-dose-rate brachytherapy using Leipzig applicators for non-melanoma localized skin cancer
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2020)

EVALUATING MMP-2 AND TGFß-RI EXPRESSION IN CIRCULATING TUMOR CELLS OF PANCREATIC CANCER PATIENTS AND THEIR CORRELATION WITH CLINICAL EVOLUTION
por: GASPARINI-JUNIOR, José Luiz, et al.
Publicado: (2019)

Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision
por: de Azevedo Santos, Tâmara Ribeiro, et al.
Publicado: (2015)

MIR-203A-3P AND MMP-2 PROTEINS ARE HIGHLY EXPRESSED IN CIRCULATING TUMOR CELLS FROM PATIENTS WITH PANCREATIC CARCINOMA
por: TARAZONA, José Gabriel Rodríguez, et al.
Publicado: (2022)

Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

Postmastectomy Radiation Therapy Bolus Associated Complications in Patients Who Underwent 2-stage Breast Reconstruction
por: de Sousa, Cecília Félix Penido Mendes, et al.
Publicado: (2022)

A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer
por: Abdallah, Emne Ali, et al.
Publicado: (2020)

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems
por: Viani, Gustavo A, et al.
Publicado: (2007)

Whole brain radiation therapy in management of brain metastasis: results and prognostic factors
por: Saito, Elisa Y, et al.
Publicado: (2006)

Circulating Tumor Cells in Desmoid Tumors: New Perspectives
por: Braun, Alexcia C., et al.
Publicado: (2021)

Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells
por: Souza e Silva, Virgílio, et al.
Publicado: (2016)

The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2008)

Fusion Cell Markers in Circulating Tumor Cells from Patients with High-Grade Ovarian Serous Carcinoma
por: Ruano, Anna Paula Carreta, et al.
Publicado: (2022)

Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer
por: Sapienza, Lucas Gomes, et al.
Publicado: (2015)

Evidence and clinical outcomes of adult soft tissue sarcomas of the extremities treated with adjuvant high-dose-rate brachytherapy – a literature review
por: Pellizzon, Antonio Cássio Assis
Publicado: (2014)

Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer
por: Pellizzon, Antônio Cássio Assis
Publicado: (2016)

Radiation treatment of prostate cancers – the contemporary role of modern brachytherapy techniques
por: Pellizzon, Antonio Cassio Assis
Publicado: (2017)

Pain relief procedures before high-dose-rate brachytherapy for non-surgical treatment of cervix cancer
por: Pellizzon, Antonio Cássio Assis
Publicado: (2018)

Public health measures, radiotherapy, and the novel coronavirus outbreak
por: Pellizzon, Antonio Cassio Assis
Publicado: (2020)

The old-style public health measures and the novel coronavirus outbreak
por: Pellizzon, Antonio Cassio Assis
Publicado: (2020)

Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion
por: Chinen, Ludmilla T Domingos, et al.
Publicado: (2014)

CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor
por: Torres, Jacqueline Aparecida, et al.
Publicado: (2023)

The Tumor Boards – is this strategy worth for developing countries?
por: Pellizzon, Antonio Cassio de Assis
Publicado: (2018)

Involved-Field Radiation Therapy for Patients With Unresectable Pancreatic Adenocarcinomas: Failure Pattern Analysis
por: Fogaroli, Ricardo C, et al.
Publicado: (2023)

Partial breast irradiation: when less could be more
por: Ambrósio, Alexandre Vasconcellos Alvim, et al.
Publicado: (2020)

Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy
por: Favareto, Sergio L, et al.
Publicado: (2021)

Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients
por: Abdallah, Emne Ali, et al.
Publicado: (2015)

Focal brain inflammation and autism
por: Theoharides, Theoharis C, et al.
Publicado: (2013)

Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2006)

Chemotherapy followed by low dose radiotherapy in childhood Hodgkin's disease: retrospective analysis of results and prognostic factors
por: Viani, Gustavo A, et al.
Publicado: (2006)

Hierarchical disruption in the Bayesian brain: Focal epilepsy and brain networks
por: Omidvarnia, Amir, et al.
Publicado: (2017)

Enantiomorphic normalization of focally lesioned brains
por: Nachev, Parashkev, et al.
Publicado: (2008)

Animal models of focal brain ischemia
por: Sicard, Kenneth M, et al.
Publicado: (2009)

High prevalence of focal and multi-focal somatic genetic variants in the human brain
por: Keogh, Michael J., et al.
Publicado: (2018)

Biomarkers of focal and diffuse traumatic brain injury
por: Vos, Pieter E
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8q0986d0hfdae8dq7ogjvq8797